Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 13 Weeks

13-Mar-17 - 11-Jun-17
Buy Ratio:39%

Up

# Net Buyers:81
# Net Sellers:125

Previous 13 Weeks

12-Dec-16 - 12-Mar-17
Buy Ratio:32%
# Net Buyers:67
# Net Sellers:145
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Valeant Pharmaceuticals International, Inc.$203.37K$166.38M  
Pfizer Inc--$56.91M  
Agios Pharmaceuticals Inc$29.38M$50.58M  
Global Blood Therapeutics, Inc.($3.75M)$48.50M  
Blueprint Medicines Corp--$43.92M  
New Net Buyers
CompanyNet Buy AmountChange
Valeant Pharmaceuticals International, Inc.$203.37K$166.38M  
Agios Pharmaceuticals Inc$29.38M$50.58M  
Corcept Therapeutics Inc$54.59K$38.41M  
Allergan Plc$21.02M$37.63M  
Biogen Inc.$16.92M$24.63M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Mylan N.V.($1.83B)($1.83B)  
Colucid Pharmaceuticals, Inc.--($716.17M)  
Esperion Therapeutics, Inc.($49.31M)($49.31M)  
Vertex Pharmaceuticals Inc / Ma($49.64M)($42.25M)  
Merck & Co., Inc.($6.84M)($13.66M)  
New Net Sellers
CompanyNet Buy AmountChange
Merck & Co., Inc.($6.84M)($13.66M)  
Biotime Inc($18.97K)($6.02M)  
Idera Pharmaceuticals, Inc.($3.99M)($4.07M)  
Amicus Therapeutics Inc($478.62K)($1.95M)  
Juno Therapeutics, Inc.($186.22K)($363.11K)